Emerging Roles of Mesenchymal Stem Cell-Derived Exosomes in Gastrointestinal Cancers

Naijian Wang,Bing Pei,Xinyi Yuan,Chengxue Yi,Dickson Kofi Wiredu Ocansey,Hua Qian,Fei Mao
DOI: https://doi.org/10.3389/fbioe.2022.1019459
IF: 5.7
2022-01-01
Frontiers in Bioengineering and Biotechnology
Abstract:Gastrointestinal tumours are the most common solid tumours, with a poor prognosis and remain a major challenge in cancer treatment. Mesenchymal stem cells (MSC) are multipotent stromal cells with the potential to differentiate into multiple cell types. Several studies have shown that MSC-derived exosomes have become essential regulators of intercellular communication in a variety of physiological and pathological processes. Notably, MSC-derived exosomes support or inhibit tumour progression in different cancers through the delivery of proteins, RNA, DNA, and bioactive lipids. Herein, we summarise current advances in MSC-derived exosomes in cancer research, with particular reference to their role in gastrointestinal tumour development. MSC-derived exosomes are expected to be a novel potential strategy for the treatment of gastrointestinal cancers.
What problem does this paper attempt to address?